COLLEGIUM PHARMACEUTICAL INC (COLL) Stock Fundamental Analysis
NASDAQ:COLL - Nasdaq - US19459J1043 - Common Stock - Currency: USD
Taking everything into account, COLL scores 6 out of 10 in our fundamental rating. COLL was compared to 193 industry peers in the Pharmaceuticals industry. While COLL belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. COLL may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
COLL had positive earnings in the past year.
COLL had a positive operating cash flow in the past year.
Of the past 5 years COLL 4 years were profitable.
Each year in the past 5 years COLL had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 2.69%, COLL belongs to the best of the industry, outperforming 84.46% of the companies in the same industry.
COLL has a better Return On Equity (18.72%) than 91.19% of its industry peers.
The Return On Invested Capital of COLL (8.30%) is better than 86.01% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for COLL is below the industry average of 14.87%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.69% | ||
| ROE | 18.72% | ||
| ROIC | 8.3% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
1.3 Margins
The Profit Margin of COLL (6.61%) is better than 84.46% of its industry peers.
COLL's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 21.39%, COLL belongs to the top of the industry, outperforming 88.08% of the companies in the same industry.
COLL's Operating Margin has improved in the last couple of years.
The Gross Margin of COLL (57.69%) is better than 66.84% of its industry peers.
COLL's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.39% | ||
| PM (TTM) | 6.61% | ||
| GM | 57.69% |
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), COLL is creating some value.
COLL has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, COLL has less shares outstanding
COLL has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.02, we must say that COLL is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.02, COLL is in line with its industry, outperforming 58.03% of the companies in the same industry.
The Debt to FCF ratio of COLL is 4.26, which is a neutral value as it means it would take COLL, 4.26 years of fcf income to pay off all of its debts.
COLL's Debt to FCF ratio of 4.26 is amongst the best of the industry. COLL outperforms 85.49% of its industry peers.
COLL has a Debt/Equity ratio of 3.30. This is a high value indicating a heavy dependency on external financing.
COLL's Debt to Equity ratio of 3.30 is on the low side compared to the rest of the industry. COLL is outperformed by 81.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.3 | ||
| Debt/FCF | 4.26 | ||
| Altman-Z | 1.02 |
ROIC/WACC0.86
WACC9.62%
2.3 Liquidity
COLL has a Current Ratio of 1.08. This is a normal value and indicates that COLL is financially healthy and should not expect problems in meeting its short term obligations.
COLL has a Current ratio of 1.08. This is amonst the worse of the industry: COLL underperforms 80.83% of its industry peers.
COLL has a Quick Ratio of 1.01. This is a normal value and indicates that COLL is financially healthy and should not expect problems in meeting its short term obligations.
COLL has a worse Quick ratio (1.01) than 75.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.08 | ||
| Quick Ratio | 1.01 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 106.69% over the past year.
Measured over the past years, COLL shows a very strong growth in Earnings Per Share. The EPS has been growing by 154.78% on average per year.
Looking at the last year, COLL shows a quite strong growth in Revenue. The Revenue has grown by 17.18% in the last year.
The Revenue has been growing by 16.31% on average over the past years. This is quite good.
EPS 1Y (TTM)106.69%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%2.76%
Revenue 1Y (TTM)17.18%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%22.66%
3.2 Future
The Earnings Per Share is expected to grow by 7.69% on average over the next years.
COLL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.64% yearly.
EPS Next Y8.96%
EPS Next 2Y5.37%
EPS Next 3Y-1.01%
EPS Next 5Y7.69%
Revenue Next Year18.28%
Revenue Next 2Y10.81%
Revenue Next 3Y4.43%
Revenue Next 5Y2.64%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
COLL is valuated cheaply with a Price/Earnings ratio of 4.97.
97.41% of the companies in the same industry are more expensive than COLL, based on the Price/Earnings ratio.
COLL's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.29.
With a Price/Forward Earnings ratio of 4.50, the valuation of COLL can be described as very cheap.
Based on the Price/Forward Earnings ratio, COLL is valued cheaper than 95.34% of the companies in the same industry.
COLL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.06.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.97 | ||
| Fwd PE | 4.5 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of COLL indicates a rather cheap valuation: COLL is cheaper than 98.45% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of COLL indicates a rather cheap valuation: COLL is cheaper than 97.41% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.27 | ||
| EV/EBITDA | 4.69 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
COLL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.55
PEG (5Y)N/A
EPS Next 2Y5.37%
EPS Next 3Y-1.01%
5. Dividend
5.1 Amount
No dividends for COLL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
32.26
+0.49 (+1.54%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners116.69%
Inst Owner Change0%
Ins Owners1.52%
Ins Owner Change3.9%
Market Cap1.04B
Analysts81.82
Price Target43.86 (35.96%)
Short Float %13.79%
Short Ratio14.43
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.4%
Min EPS beat(2)1.96%
Max EPS beat(2)12.85%
EPS beat(4)3
Avg EPS beat(4)5.22%
Min EPS beat(4)-0.88%
Max EPS beat(4)12.85%
EPS beat(8)7
Avg EPS beat(8)13.83%
EPS beat(12)8
Avg EPS beat(12)-13.44%
EPS beat(16)8
Avg EPS beat(16)-30.16%
Revenue beat(2)1
Avg Revenue beat(2)0.28%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)1.34%
Revenue beat(4)2
Avg Revenue beat(4)-0.03%
Min Revenue beat(4)-1.05%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-1.39%
Revenue beat(12)5
Avg Revenue beat(12)-0.62%
Revenue beat(16)6
Avg Revenue beat(16)-5.22%
PT rev (1m)0%
PT rev (3m)0.47%
EPS NQ rev (1m)-11.83%
EPS NQ rev (3m)1.94%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.25%
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)0.33%
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)0.22%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.97 | ||
| Fwd PE | 4.5 | ||
| P/S | 1.56 | ||
| P/FCF | 5.27 | ||
| P/OCF | 5.22 | ||
| P/B | 4.42 | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.69 |
EPS(TTM)6.49
EY20.12%
EPS(NY)7.16
Fwd EY22.2%
FCF(TTM)6.12
FCFY18.96%
OCF(TTM)6.17
OCFY19.14%
SpS20.67
BVpS7.29
TBVpS-23.41
PEG (NY)0.55
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.69% | ||
| ROE | 18.72% | ||
| ROCE | 12.41% | ||
| ROIC | 8.3% | ||
| ROICexc | 10.04% | ||
| ROICexgc | N/A | ||
| OM | 21.39% | ||
| PM (TTM) | 6.61% | ||
| GM | 57.69% | ||
| FCFM | 29.59% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
ROICexc(3y)16.99%
ROICexc(5y)14.94%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)16.56%
ROCE(5y)13.94%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y15.58%
ROICexc growth 5YN/A
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
F-Score4
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.3 | ||
| Debt/FCF | 4.26 | ||
| Debt/EBITDA | 2.33 | ||
| Cap/Depr | 0.99% | ||
| Cap/Sales | 0.28% | ||
| Interest Coverage | 2.13 | ||
| Cash Conversion | 59.7% | ||
| Profit Quality | 447.8% | ||
| Current Ratio | 1.08 | ||
| Quick Ratio | 1.01 | ||
| Altman-Z | 1.02 |
F-Score4
WACC9.62%
ROIC/WACC0.86
Cap/Depr(3y)142.93%
Cap/Depr(5y)207.67%
Cap/Sales(3y)41.34%
Cap/Sales(5y)49.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)106.69%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%2.76%
EPS Next Y8.96%
EPS Next 2Y5.37%
EPS Next 3Y-1.01%
EPS Next 5Y7.69%
Revenue 1Y (TTM)17.18%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%22.66%
Revenue Next Year18.28%
Revenue Next 2Y10.81%
Revenue Next 3Y4.43%
Revenue Next 5Y2.64%
EBIT growth 1Y-25.89%
EBIT growth 3Y89.16%
EBIT growth 5YN/A
EBIT Next Year146.84%
EBIT Next 3Y28.51%
EBIT Next 5Y14.2%
FCF growth 1Y12%
FCF growth 3Y25.98%
FCF growth 5Y56.88%
OCF growth 1Y11.99%
OCF growth 3Y25.54%
OCF growth 5Y49.12%